HuGE Literature Finder
Records 1-5
Cytokine Status Of Serum In Ovarian Cancer Patients With Different Tumor Neoadjuvant Chemotherapy Response.
Anti-cancer agents in medicinal chemistry 2017 Jan . Antoneeva Inna I, Abakumova Tatyana V, Dolgova Dinara R, Gening Tatyana P, Pirmamedova Sabina S, Myasnikova Dinara F, Gening Snezhanna |
Common variants in IL-1RN, IL-1? and TNF-? and the risk of ovarian cancer: a case control study.
Central-European journal of immunology 2017 42 (2): 150-155. Ahmed Amira Ben, Zidi Sabrina, Sghaier Ikram, Ghazouani Ezzeddine, Mezlini Amel, Almawi Wassim, Loueslati Besma Yacou |
The truncated splice variant of peroxisome proliferator-activated receptor alpha, PPAR?-tr, autonomously regulates proliferative and pro-inflammatory genes.
BMC cancer 2015 15 488. Thomas Maria, Bayha Christine, Klein Kathrin, Müller Simon, Weiss Thomas S, Schwab Matthias, Zanger Ulrich |
Variation in NF-?B signaling pathways and survival in invasive epithelial ovarian cancer.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2014 Jul 23 (7): 1421-7. Block Matthew S, Charbonneau Bridget, Vierkant Robert A, Fogarty Zachary, Bamlet William R, Pharoah Paul D P, , , , Rossing Mary Anne, Cramer Daniel, Pearce Celeste Leigh, Schildkraut Joellen, Menon Usha, Kjaer Susanne K, Levine Douglas A, Gronwald Jacek, Culver Hoda Anton, Whittemore Alice S, Karlan Beth Y, Lambrechts Diether, Wentzensen Nicolas, Kupryjanczyk Jolanta, Chang-Claude Jenny, Bandera Elisa V, Hogdall Estrid, Heitz Florian, Kaye Stanley B, Fasching Peter A, Campbell Ian, Goodman Marc T, Pejovic Tanja, Bean Yukie T, Hays Laura E, Lurie Galina, Eccles Diana, Hein Alexander, Beckmann Matthias W, Ekici Arif B, Paul James, Brown Robert, Flanagan James M, Harter Philipp, du Bois Andreas, Schwaab Ira, Hogdall Claus K, Lundvall Lene, Olson Sara H, Orlow Irene, Paddock Lisa E, Rudolph Anja, Eilber Ursula, Dansonka-Mieszkowska Agnieszka, Rzepecka Iwona K, Ziolkowska-Seta Izabela, Brinton Louise A, Yang Hannah, Garcia-Closas Montserrat, Despierre Evelyn, Lambrechts Sandrina, Vergote Ignace, Walsh Christine S, Lester Jenny, Sieh Weiva, McGuire Valerie, Rothstein Joseph H, Ziogas Argyrios, Lubi?ski Jan, Cybulski Cezary, Menkiszak Janusz, Jensen Allan, Gayther Simon A, Ramus Susan J, Gentry-Maharaj Aleksandra, Berchuck Andrew, Wu Anna H, Pike Malcolm C, Van Den Berg David, Terry Kathryn L, Vitonis Allison F, Ramirez Starr M, Rider David N, Knutson Keith L, Sellers Thomas A, Phelan Catherine M, Doherty Jennifer A, Johnatty Sharon E, deFazio Anna, Song Honglin, Tyrer Jonathan, Kalli Kimberly R, Fridley Brooke L, Cunningham Julie M, Goode Ellen |
TNF polymorphisms and prostate cancer risk.
The Prostate 2008 Mar 68 (4): 400-7. Danforth Kim N, Rodriguez Carmen, Hayes Richard B, Sakoda Lori C, Huang Wen-Yi, Yu Kai, Calle Eugenia E, Jacobs Eric J, Chen Bingshu E, Andriole Gerald L, Figueroa Jonine D, Yeager Meredith, Platz Elizabeth A, Michaud Dominique S, Chanock Stephen J, Thun Michael J, Hsing Ann |
- Page last reviewed:Oct 1, 2020
- Page last updated:Jan 15, 2021
- Content source: